Pharmaceutical Investing Cyclacel Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Sapacitabine With Olaparib in BRCA Mutant Breast Cancer
Pharmaceutical Investing Cyclacel Announces Presentation of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Annual Meeting
Pharmaceutical Investing Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
Pharmaceutical Investing Cyclacel Announces Notice of Grant of New European Patent Covering Sapacitabine Pharmaceutical Formulations
CHARBONE Hydrogen and ABB Sign Agreement to Advance North American Green Hydrogen Production Facilities
CHARBONE Hydrogene et ABB signent une entente pour accelerer les usines de production d'hydrogene vert en Amerique du Nord
Global Nickel Mining Market Size Forecasted to Reach $100 Billion By 2034 as Demand for Electric Vehicles Rises
Cizzle Brands Corporation Schedules Second Fiscal Quarter 2025 Financial Results Webcast for Thursday, March 27, 2025 at 4:30 PM ET
